Olink Holding AB (publ) (OLK)

23,01 -0,01 (-0,04%) Börsenschluss: 04:00PM EDT

Olink Holding AB (publ)

Salagatan 16F
Uppsala 753 30
Sweden
46 1 84 44 39 70
https://www.olink.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 707

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Jon Heimer	CEO & Director	695,17k	N/A	1967
Mr. Carl Raimond	Interim Chief Commercial Officer & President	N/A	N/A	1971
Mr. Oskar Hjelm	Chief Financial Officer	N/A	N/A	1985
Ms. Anna Marsell	Chief Operating Officer	N/A	N/A	1978
Mr. Jan Medina CFA	Vice President of Investor Relations & Capital Markets	N/A	N/A	N/A
Ms. Linda Ramirez-Eaves Esq.	General Counsel	N/A	N/A	1972
Andrea Prander	Corporate Communications Manager	N/A	N/A	N/A
Mr. Elias Berglund	Chief People Officer	N/A	N/A	1978
Mr. Rickard El Tarzi	Chief Strategy & Product Officer	N/A	N/A	1986
Ms. Maria Liminga Bjork	Chief Research & Development Officer	N/A	N/A	1969

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Corporate Governance

Olink Holding AB (publ)s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.